1. How do Jerome Groopman and Jeffrey L. Reynolds differ in their descriptions of the drug AZT? How do these descriptions compare to their opinions about protease inhibitors? Explain your answers.
2. Kevin B. Zeese is the president of the public policy organization Common Sense for Drug Policy. Barry R. McCaffrey directs the federal Office of National Drug Control Policy. How are the authors’ backgrounds evident in their views of medical marijuana? Which of these viewpoints is more convincing, and why? Does knowing the authors’ backgrounds influence your assessment of their arguments? If so, in what way"